NOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL.
In the European Economic Area, with respect to any Member State that has implemented Directive 2003/71/EC, as amended, (together with any applicable implementing measures in any Member State, the "Prospectus Directive") this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.
The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available. The issuer of the securities has not registered, and does not intend to register, any portion of the offering in the United States, and does not intend to conduct a public offering of securities in the United States.
These materials shall not constitute or form part of an offer or invitation to sell or the solicitation of an offer to buy or subscribe, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.
This announcement is an advertisement for the purposes of the Prospectus Rules of the UK Financial Conduct Authority (the "FCA") and not a prospectus. Investors should not purchase or subscribe for any ordinary shares referred to in this announcement except on the basis of information in the prospectus published by Georgia Healthcare Group PLC today in connection with the proposed admission of its ordinary shares to the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the London Stock Exchange plc.
Georgia Healthcare Group announces publication of Prospectus in connection with its IPO
Following an announcement by Georgia Healthcare Group PLC (the "Company") earlier today in relation to the initial public offering of 38,681,820 new ordinary shares in the capital of the Company (the "IPO") at a price of 170 pence per share, the Company announces that a prospectus dated 9 November 2015 (the "Prospectus") has today been approved by the UK Listing Authority.
A copy of the Prospectus will shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM. In addition, the Prospectus will also shortly be available to view on the website of the Company, http://ghg.com.ge/, and at the Company's offices at 84 Brook Street, London, W1K 5EH, United Kingdom and No. 40, Vazha-Pshavela Avenue, 0177, Tbilisi, Georgia.
More information about Georgia Healthcare Group PLC is available on its website at: http://ghg.com.ge/.
Enquiries
Ekaterina (Eka) ShavgulidzeHead of Investor Relations
Georgia Healthcare Group
Tel: +995 32 2 44 44 44 (4205)
ir@ghg.com.ge
Roger BarbManaging Director
Citigroup Global Markets Limited
Tel:+44 (0) 20 7986 8202
roger.barb@citi.com
Reg Hoare/Jade Neal/Gina BellMHP Communications (press enquiries)
Tel: + 44 (0) 3128 8139
ghg@mhpc.com 
